FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Pantoprazole Sodium from XLCare Pharmaceuticals Inc., approving a change to this generic product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Pantoprazole sodium (pantoprazole sodium)

Snippet

SUPPL AP for PANTOPRAZOLE SODIUM (PANTOPRAZOLE)